Resources

With Canada becoming the first G7 nation to legalize recreational cannabis, this white paper from KGK Science examines the country's pioneering regulatory journey and its ripple effects on research, commerce, and consumer health. Backed by original survey data and regulatory analysis, the paper explores usage patterns, legislative milestones, clinical research...

The randomized controlled trial (RCT) has long been considered the gold standard in clinical research—but is it always the best fit for the complex, multi-targeted nature of dietary supplements? This thought-provoking white paper from KGK Science explores the limitations of traditional RCTs in the context of nutrition science and proposes...

As interest in probiotics surges, their inclusion in infant nutrition products has created both opportunity and controversy. This white paper explores the evolving regulatory landscape and growing scientific evidence surrounding probiotics in infant formulas and supplements. Authored by experts at KGK Science, it highlights the critical importance of well-designed clinical...

Clinical trials offer a powerful way to differentiate your dietary supplement—but only if designed with regulatory compliance in mind. This white paper outlines critical strategies for designing trials that align with FDA and FTC guidelines while generating credible, claim-supporting evidence. Learn how to choose the right endpoints, define your target...

As the use of consumer surveys and subjective questionnaires grows in the clinical trial space, Patient Reported Outcomes (PROs) are gaining attention as tools for substantiating structure/function claims on food and dietary supplement products. This white paper, authored by Dr. Corey Hilmas and Andrew Charrette of KGK Science, explores how...

In the wake of recent trade press confusion, KGK Science sets the record straight on FTC’s Health Products Compliance Guidance. This letter critically analyzes misleading interpretations around substantiation standards, including the use of randomized controlled trials (RCTs), the definition of structure-function claims, and the difference between FTC and FDA expectations....